SPX4,136.05+78.21 1.93%
DIA330.26+3.81 1.17%
IXIC12,069.34+328.69 2.80%

--Morgan Stanley Adjusts Eli Lilly and Co.'s Price Target to $369 from $364, Keeps Overweight Rating

MT Newswires · 04/29/2022 08:27

Please log in to view news